Testimony Before the FDA’s Pharmacy Compounding Advisory Committee Regarding the List of Drug Products Withdrawn or Removed from the Market Because They Have Been Found to be Unsafe or Not Effective

View as PDF

In testimony before a meeting of the Food and Drug Administration’s (FDA’s) Pharmacy Compounding Advisory Committee, Public Citizen urged that all injectable neomycin products be added to the list of drugs that have been withdrawn or removed from the market because they were deemed unsafe or not effective and that therefore may not be compounded. We also recommended that the FDA implement a new policy of simultaneously initiating the process for updating the list of withdrawn or removed drugs whenever the agency announces that a drug was removed from the market because of safety or effectiveness concerns.

View our other work related to pharmacy compounding.